Kohnan Shoji (7516) · PolicyIncrease in the Valuation of Listed Holdings
Cross-Shareholdings Held to Maintain and Strengthen Business Relationships
First written in FY2019. . Latest entry: FY2026.
7entries
8years
0from disclosures
How it moved
Same theme, other companies
Business relationships and sales policy through strategic shareholdingsA theme 618 companies write about · 0 as a headwind · 561 as a tailwind
The whole theme swung hardest in 2019: 18 of 135 companies on the "Worse" side.
Ridges = years it wrote progress, valleys = years it wrote worse. Most hopeful companies at the back. Drag to turn, scroll to zoom, right-drag to pan. On a phone, two fingers turn and pinch to zoom; one finger scrolls the page.
Showing 14 of the 198 companies compared. The sentences above are computed from all 198.Comparing 200 of the theme's 623 threads.Full recordFilings, disclosures and news, newest first
- FY2026Increase in the Valuation of Listed HoldingsAnnual report
「Unlisted shares 3 ¥2,169 million Shares other than unlisted shares 7 ¥1,735 million」
Policy-held shares comprised 3 unlisted issues valued at ¥2,169 million and 7 listed issues valued at ¥1,735 million. The value of listed shares increased from ¥820 million in the previous fiscal year, and the disclosure also notes an increase in the number of SANEI shares through regular purchases. - FY2024Transfer of unlisted shares to shares of an affiliateAnnual report
「Unlisted shares 3 ¥2,169 million Shares other than unlisted shares 7 ¥820 million」
Unlisted shares comprised 3 issues valued at ¥2,169 million. The disclosure states that, following the conversion of HI Hirose into a subsidiary, the company’s shares, previously held for the purpose of a business alliance, were transferred to shares of an affiliate, resulting in the decrease in the number of issues. Listed policy-held shares comprised 7 issues, unchanged from the previous fiscal year. - FY2023Decrease in the number of listed policy-held share issues and saleAnnual report
「Shares other than unlisted shares 7 ¥712 million Taisho Pharmaceutical Holdings Co., Ltd. — ¥330 million Following a review of the rationale for holding the shares, all holdings were sold during the current fiscal year」
Listed policy-held share issues decreased from 8 in the previous fiscal year to 7, and the amount recognized on the balance sheet was ¥712 million. The disclosure states that all shares of Taisho Pharmaceutical Holdings were sold following a review of the rationale for holding them. - FY2022Increase in the number of listed policy-held share issuesAnnual report
「Shares other than unlisted shares 8 ¥656 million」
The number of listed policy-held share issues increased from 7 in the previous fiscal year to 8, and the amount recognized on the balance sheet was ¥656 million. The disclosure states that the number of SANEI株式会社 shares increased through regular purchases via a business-partner shareholding association. - FY2021Increase in the Valuation of Listed HoldingsAnnual report
「Shares other than unlisted shares 7 ¥684 million」
Policy-held shares comprised 4 unlisted issues valued at ¥3,203 million and 7 listed issues valued at ¥684 million. The number of listed issues and shares was unchanged from the previous fiscal year, while the carrying amount increased from ¥617 million to ¥684 million. - FY2020Increase in holdings and balancesAnnual report
「Unlisted shares 4 ¥3,203 million Shares other than unlisted shares 7 ¥617 million」
Policy-held shares comprised 4 unlisted issues valued at ¥3,203 million and 7 listed issues valued at ¥617 million. One unlisted issue valued at ¥2,168 million increased as a result of the acquisition of 建デポ. The holding policy is to maintain and strengthen ongoing business relationships, with the rationale to be reported to the Board of Directors periodically. - FY2019First statedAnnual report
「10 issues, ¥1,724 million」
The Company held 10 investments in shares held for purposes other than pure investment, with a balance-sheet carrying amount of ¥1,724 million. The stated purpose for each holding was to maintain and strengthen ongoing business relationships.